Mycophenolate Sodium Patent Expiration
Mycophenolate Sodium is Used for preventing organ rejection in patients who have received allogeneic renal transplants. It was first introduced by Novartis Pharmaceuticals Corp
Mycophenolate Sodium Patents
Given below is the list of patents protecting Mycophenolate Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Myfortic | US6306900 | Enteric coated pharmaceutical compositions |
Feb 27, 2018
(Expired) | Novartis |
| Myfortic | US6025391 | Enteric-coated pharmaceutical compositions of mycophenolate |
Apr 10, 2017
(Expired) | Novartis |
| Myfortic | US6172107 | Entric-coated pharmaceutical compositions |
Apr 10, 2017
(Expired) | Novartis |
Mycophenolate Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List